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glyceraldehyde-3-phosphate dehydrogenase (GAPDH) results in reduced
enzyme activity, thereby reducing energy metabolites. This study aims to
determine whether PARP inhibition modulates the activity and level of poly
(ADP-ribosylation) of GAPDH, along with energy substrates within dia-
betic skeletal muscle after IR.
Methods: Two groups of db/db mice underwent 1.5 hours of unilat-
eral hind limb ischemia, followed by 24 hours reperfusion. The treatment
group (PJ) received 6 dosages of 30 mg/kg of PJ34, a PARP inhibitor, at
5 minutes before reperfusion, at 15 minutes, and at 2, 6, 12, and 18 hours
after reperfusion. The untreated group received equivalent volumes of
lactated Ringer’s (LR) vehicle at the same time points. Uninjured sham mice
were used as the control. Hind limb skeletal muscle tissue was harvested at
24 hours reperfusion to evaluate PARP and GAPDH activity, total GAPDH
expression and poly (ADP-ribosylated) GAPDH, in addition to skeletal
muscle ATP and lactate.
Results: PJ34 treatment significantly reduced PARP activity and in-
creased GAPDH activity relative to LR at 24 hours’ reperfusion (Table).
GAPDH expression was significantly lower in the PJ group. Poly (ADP-
ribosylation) of GAPDH was significantly reduced in the PJ group. PJ34
treatment significantly increased skeletal muscle ATP and lactate compared
with LR.
Conclusions: These data indicate that PARP inhibition by PJ34 in-
creased GAPDH activity, tissue lactate, and ATP, and decreased poly (ADP-
ribosylation) of GAPDH after IR. The resulting increase in tissue ATP and
lactate may provide mechanistic insight into how PARP inhibition mediates
protection against skeletal muscle IR injury.
Table.
LR PJ
P(n  6-16) (n  6-10)
PARP activity (% control) 300  48 221  20 .0043
GAPDH activity (U/2-
mg protein) 0.31  0.04 0.5  0.04 .0005
GAPDH expression (%
control) 122.5  8 94  6 .0008
GAPDH poly (ADP-
ribosylation) (AU) 1.5  0.23 0.41  0.13 .0002
Muscle ATP (nmol/g
tissue) 0.3  0.1 0.84  0.3 .0046
Muscle lactate (g/g
tissue) 229  10 375.6  48 .00004
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Introduction and objectives: Dietary restriction (DR; reduced food
intake without malnutrition) effectively reduces the acute response to sur-
gical stress in preclinical models likely by anti-inflammatory and antioxidant
mechanisms. Leveraging a novel murine carotid focal stenosis model, we
tested the hypothesis that DR would attenuate the arterial intimal hyperpla-
sia (IH) response.
Methods: A focal stenosis in 8-week-old C57BL/6J mice was created
by placing a 9-0 nylon suture tie around the distal common carotid artery
and an external 35-gauge needle mandrel (outer diameter, .014 mm) and
then removing the mandrel (78% lumen diameter reduction, 90% flow
reduction). Animals received 60 kcal% fat diet-induced obesity (DIO) chow
at baseline, and then the same chow (n  10) or 10 kcal% fat normal chow
(NC; n  10) postoperatively. One group (n  20) had a water-only fast
(DR) 72 hours before focal stenosis creation, then NC. Tissues were
perfusion-fixed 4 weeks later. Immunohistochemical staining was performed
for CD31, F4/80, and -actin.
Results: Switching to NC postoperatively reduced IH (P  .001) and
adventitial macrophages (P  .05; Fig). Brief preoperative DR even further
attenuated IH (P  .001) and yielded increased IH neovessel formation
(P  .05).
Conclusions: This murine focal carotid stenosis model offers a
straightforward method to dissect the mechanisms of arterial IH. Postoper-
ative NC rather than DIO attenuates IH. Short-term preoperative DR
further downregulates the longer-term arterial IH response, and this is
associated with less macrophage infiltration and increased IH neovascularity.
These dietary manipulations potentially offer a practical approach to extend
the durability of acute vascular interventions.
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Introduction and objectives: Intimal hyperplasia (IH) remains the
leading cause for prosthetic arterial graft failure. A composite of electrospun
polymers, such as nondegradable polymer, polyethylene terephthalate
(ePET) with a degradable polymer, and polyglycolic acid (PGA) infused
with biologically active material that can prevent the development of IH is an
appealing alternative to other clinically used grafts made of polytetrafluoro-
ethylene (PTFE).
Methods: Electrospun grafts were synthesized from ePET, copolymer
of ePET/ePGA (90:10, PET/PGA mixture resulting in a single fiber), or
cospun ePET/ePGA (90:10, individual PET and PGA fibers interspersed).
Pieces of grafts (5 mm2) were incubated in saline at 37°C for 7, 14, and 21
days and imaged using scanning electron microscopy. Attachment and
viability of human aortic smooth muscle cells (HAoSMC) seeded onto the
materials were analyzed 3 and 48 hours later, and comparisons were made
with HAoSMCs seeded on PTFE. In addition, siGLO Red (control short
interfering [si]RNA with DyLight-547 fluorescent tag) was infused into
PGA fibers of the cospun graft and siRNA degradation was observed using
confocal microscopy.
Results: Scanning electron microscopy images indicated breakage of
ePET/ePGA copolymer fibers at days 14 and 21, whereas the cospun
ePET/ePGA material showed intact ePET fibers and fragmented ePGA
fibers. Compared with PTFE, HAoSMC demonstrated a greater affinity and
viability towards electrospun materials and significantly more to cospun
ePET/ePGA. Integration of siGLO Red into PGA fibers of cospun grafts
was successful, and red fluorescent density decreased 90% in 2 weeks,
indicating release of siGLO Red.
Conclusions: Cospun ePET/ePGA remained intact after PGA degra-
dation, whereas the copolymer showed fiber breaks and fragility, making
cospun material more favorable as prosthetic arterial bypass grafts. Electro-
spun composite grafts did not impair HAoSMC attachment and growth.
siGLO Red was successfully incorporated and released from cospun ePET/
ePGA. Electrospun composite grafts can act as a delivery platform for gene
silencing to control IH.
Midterm Results of a Pilot Study on Bone Marrow Aspirate Concen-
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Introduction and objectives: Bone marrow aspirate concentrate
(BMAC), which contains cells with regenerative properties, has been studied
as a treatment for critical limb ischemia (CLI). We report the intermediate-
term results of a BMAC pilot study.
Methods: A prospective, randomized, placebo-controlled trial of
BMAC in CLI was conducted in Rutherford 4 (rest pain) and Rutherford 5
(limited tissue loss) patients. All patients were poor candidates for conven-
tional revascularization due to anatomic or physiologic considerations.
Patients were treated in a single session with aspiration of bone marrow and
preparation of BMAC injectate or placebo (peripheral blood). Forty injec-
tions were made percutaneously into the ischemic extremity and distributed
in a linear fashion along the ischemic gradient. An initial analysis previously
reported 3-month data and we are now reporting the 12-month (interme-
diate) follow-up.
Results:Of 48 patients who were treated (mean age, 69.5 years; range,
42-93), 18 (37.5%) were Rutherford 4 and 30 (62.5%) were Rutherford 5.
Fig.
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At 1 year, only one amputation and no deaths occurred among the Ruther-
ford 4 patients. However in Rutherford 5 patients, amputations occurred in
39% (n  9) of BMAC vs 71% (n  5) of controls (P  .020), and deaths
occurred in 17% (n  4) of BMAC vs 14% (n  1) of controls (P  1.0).
Median time to amputation was 85 days in BMAC vs 55 days in control.
Conclusions:At 1 year, Rutherford 4 patients in the combined control
and treatment group had a low event rate for death or major limb amputa-
tion of 7% (1 of 14). A continued trend toward reduced amputation is seen
in patients with tissue loss (Rutherford 5) treated with BMAC, with no
adverse effect on survival and no BMAC-related complications. A pivotal
study has been initiated to further explore these promising data.
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Introduction and objectives: Although previous reports have dem-
onstrated the efficacy of catheter-directed thrombolytic therapy and iliac
vein stenting for the management of iliofemoral DVT, functional outcomes
remain undefined. The purpose of this study was to determine long-term
outcomes and functional quality of life among patients treated with iliac vein
stenting.
Methods:Records of all patients treated with iliac vein stent placement
between March 2006 and March 2011 were examined for primary patency,
assisted primary patency, and secondary patency. Long-term functional
outcomes were measured quantitatively, including ongoing symptoms and
return to work status.
Results: During the study interval, 32 patients (33 limbs) underwent
iliac vein stent placement. Of these 23 (72%) were women, with an average
age of 43 years. Twenty-five patients (78%) were diagnosed with acute DVT,
89% of which occurred in the left leg. Catheter-directed thrombolysis was
used in 23 of 25 patients (92%) with acute DVT. All patients treated with
lysis and stenting presented with pain and edema in the affected limb.
One-year primary, assisted primary, and secondary patencies were 75%, 96%,
and 96%, respectively. Freedom from reintervention at 1 year was 83%.
Treatment was associated with a sustained significant reduction in pain (91%
vs 6%, P .001) and edema (97% vs 12%, P .001) at a mean follow-up of
29 months (range, 5-83 months), at which time 89% of patients were
reported to be at their baseline pre-DVT functional status with return to
work.
Conclusions: Aggressive therapy of symptomatic iliac vein stenosis or
occlusion with venography, catheter-directed thrombolysis, and iliac vein
stent placement provides durable patency and freedom from reintervention.
Most patients can anticipate good functional recovery with decreased pain,
edema and a high likelihood of returning to work.
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Introduction and objectives: Colonic ischemia is a well-documented
complication after aortic reconstruction. During abdominal aortic aneurysm
operations, the inferior mesenteric artery distribution may be affected, thus
compromising the blood supply to the left colon with subsequent ischemia.
The rectum, particularly the middle to lower rectum, is primarily supplied by
the internal iliac artery and its branches. The incidence of isolated rectal
ischemia has not previously been documented. This study reviews the
incidence of isolated rectal ischemia after aortic reconstruction.
Methods: All patients who underwent aortic reconstruction from July
1995 to November 2008 at a single institution were prospectively entered
into a database. Patients with isolated rectal ischemia were analyzed retro-
spectively with respect to age, sex, aortic procedure, pathology, and treat-
ment.
Results: During the study period, 2315 patients underwent aortic
interventions. Flexible lower endoscopy and/or exploratory laparotomy
were performed postoperatively for the assessment of ischemia. Twenty-six
patients (1%) had colorectal involvement of bowel ischemia. Twelve patients
were excluded due to concurrent left (n  1), sigmoid (n  10), or
ascending (n 1) colon involvement. Fourteen patients (0.6%) had findings
of isolated rectal ischemia. Six patients (40%) were managed nonoperatively,
and eight (57.1%) required operative intervention. The nonoperatively
treated patients (4 men, 2 women) were a mean age of 64 years. The
operatively treated patients (4 men and 4 women) were a mean age of 79
years.
Conclusions: Rectal ischemia is a rare but under-reported complica-
tion after aortic reconstruction. The etiology of isolated rectal ischemia has
been attributed to microembolization; however, pathologic examination has
not consistently demonstrated this. The etiology of isolated rectal ischemia
remains unclear and is presumed to be multifactorial. Clinical suspicion for
rectal ischemia, even in the absence of sigmoid or left colonic distribution,
should be considered after aortic reconstruction.
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